J0872 HCPCS Level II code: Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
J0872 is the HCPCS code for “Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
Short description: Daptomycin (xellia) unrefrig
HCPCS · United States
Medicare details
The indicators CMS publishes with J0872 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2024
Where J0872 sits
- 1J codesDrugs administered other than orally
- 2Active code J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0872 mean?
J0872 is the HCPCS code for “Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0872?
CMS lists J0872’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0872
All J codesJ0834Injection, cosyntropin, 0.25 mgJ0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gramJ0841Injection, crotalidae immune f(ab')2 (equine), 120 mgJ0850Injection, cytomegalovirus immune globulin intravenous (human), per vialJ0870Injection, imetelstat, 1 mgJ0871Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mgJ0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mgJ0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mgJ0875Injection, dalbavancin, 5 mgJ0877Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mgJ0878Injection, daptomycin, 1 mgJ0879Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)